Watch-and-wait OK in low-tumor burden follicular lymphoma Medical Xpress An initial watch-and-wait strategy does not have a detrimental effect on the freedom from treatment failure or overall survival rate in selected patients with low-tumor burden follicular lymphoma compared with patients initially treated with rituximab ... |
